Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

10 Pivotal Studies To Look Out For In 2024

Jan 29 2024

• By Alexandra Shimmings

Clinical Trial — • Source: Shutterstock

Related Content

AbbVie Strikes Again By Teeing Up $8.7bn Offer For Cerevel

Dec 06 2023

Lack Of Efficacy, Not Safety, Dooms Merck KGaA’s BTK Inhibitor

Dec 06 2023

Sanofi Matches, But Does Not Better, Amgen In OX40 Contest

Oct 17 2023

Vertex Gears Up For Major Milestones, Starting With Sickle Cell Launch And Pain Drug Readout

Nov 07 2023

Lilly Wows ADA Crowd With Obesity Data Across Three-Drug Incretin Portfolio

Jun 27 2023

Blow To Roche Growth Prospects As TIGIT Lung Cancer Trial Fails

May 11 2022

Lilly To Deliver More Proof Points In Obesity, Keep Building Pipeline In 2024

Jan 23 2024

Related Companies

Sanofi

GSK plc

Amgen, Inc.

Glenmark Pharmaceuticals Limited

Ichnos Glenmark Innovation

ImageneBio, Inc.

Cerevel Therapeutics Holdings, Inc.

Karuna Therapeutics, Inc.

Bristol Myers Squibb Company

Johnson & Johnson

Neumora Therapeutics, Inc.

Merck & Co., Inc.

Roche Holding AG

CRISPR Therapeutics AG

Vertex Pharmaceuticals Incorporated

Novo Nordisk A/S

Eli Lilly and Company

Additional Topics

Clinical Trials Companies Research & Development Evaluate Data Scrip Perspectives Cancer Dermatology Immune Disorders Metabolic Disorders Neurology Respiratory BioPharmaceutical

More from Scrip Perspectives

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window